LLY Eli Lilly and Co
- 891.680
- +46.370+5.49%
- 892.320
- +0.640+0.07%
Eli Lilly and Co News
Eli Lilly and Co | 10-Q: Q2 2024 Earnings Report
Eli Lilly and Co | 8-K: Current report
Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Officer Seymour Melissa
Eli Lilly and Co | SC TO-T/A: Third party tender offer statement (Amendment)
Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Seymour Melissa
Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Brooks Gordon J.
Eli Lilly and Co | SC TO-T: Third party tender offer statement
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Hedley Mary Lynne
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 8-K: Eli Lilly Announces Anat - Ashkenazi to Resign as Executive Vice President and Chief Financial Officer
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | SC TO-C: Written communication relating to an issuer or third party tender offer
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Analysis
Price Target
No Data
